Bayer Aktiengesellschaft against Moderna, Inc. — live side-by-side technical comparison.
Prices as of 2026-09-23T15:37:33+00:00 UTC · updates daily
MRNA leads 5 of the 5 windows we measure — over 1 month BAYN.DE is +1.7% and MRNA +31.1%; over year to date BAYN.DE is +33.2% and MRNA +517.5%.
| BAYN.DE | MRNA | |
|---|---|---|
| Price | $49.31 | $182.11 |
| 1 day | -0.5% | -0.2%lead |
| 5 days | +0.7% | +25.1%lead |
| 1 month | +1.7% | +31.1%lead |
| 6 months | +28.2% | +255.1%lead |
| Year to date | +33.2% | +517.5%lead |
| 52-week position | 84% of range | 94% of range |
| 52-week range | $25.78–$53.92 | $22.28–$192.31 |
| vs 50-day average | above $48.45 | above $104.86 |
| vs 200-day average | above $42.54 | above $62.57 |
| RSI (14) | 50 | 70 |
| Next earnings | 2026-11-03 | 2026-11-05 |
BAYN.DE trades at $49.31, above its 50-day average of $48.45, and above the 200-day at $42.54. It sits at 84% of its 52-week range ($25.78–$53.92); 14-day RSI is 50, in neutral territory; an average session moves it about 2.5%. For levels, the first level overhead is $50.00 (1.4% away) and the first support below is $48.45 (1.7% down). On the checklist the page runs for every asset, 4 of 6 checks read bullish — the lean is bullish.
MRNA trades at $182.11, above its 50-day average of $104.86, and above the 200-day at $62.57. It sits at 94% of its 52-week range ($22.28–$192.31); 14-day RSI is 70, in overbought territory; an average session moves it about 6.3%. For levels, the first level overhead is $182.56 (0.2% away) and the first support below is $175.00 (3.9% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
MRNA is the more volatile of the two — an average session moves it 6.3% against 2.5% for BAYN.DE, so an identical position size carries roughly 2.5× the daily risk.
The comparison turns on those levels: BAYN.DE clearing $50.00 or losing $48.45; MRNA clearing $182.56 or losing $175.00. Until one of them gives way, the relative reading above stands.